KIN-4050 analogs (Kinentia)

N/A

Report date: 2025/01/26 18:31:35
NME

Base Information

Drug NameKIN-4050 analogs (Kinentia)
Drug Alias NameMAP kinase inhibitors (Kinentia)ERK inhibitors (Kinentia)KIN-2118
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-activated protein kinase inhibitors
TargetsMitogen-activated protein kinase
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKinentia Biosciences Llc
China Registration ClassN/A

Develop Information

Active CompaniesKinentia Biosciences Llc
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A